These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5336132)

  • 1. [Clinical and lymphographic checking of progress in lymphogranulomatosis and reticulum cell sarcoma under treatment with Natulan].
    Obrecht P; Strickstrock KH; Weissleder H
    Eur J Cancer (1965); 1966 Feb; 2(1):59-68. PubMed ID: 5336132
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical experience with ibenzmethyzin (Natulan) in the treatment of lymphomas and solid tumours.
    Holsti LR; Hjelt AL
    Ann Med Intern Fenn; 1967; 56(3):119-24. PubMed ID: 5630600
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of a methyl hydrazine derivative (natulan), especially in Hodgkin's disease.
    Hansen MM; Hertz H; Videaek A
    Acta Med Scand; 1966 Aug; 180(2):211-24. PubMed ID: 5329155
    [No Abstract]   [Full Text] [Related]  

  • 4. [Our experience in the treatment of Hodgkin's disease and other reticulopathies with Ro4-6467 (Natulan)].
    Arroyo de la Fuente F; Lasheras Garde J; Triginer Boixeda J
    Sangre (Barc); 1966; 11(3):265-70. PubMed ID: 6012465
    [No Abstract]   [Full Text] [Related]  

  • 5. Procarbazine (Natulan) in the treatment of Hodgkin's disease and other lymphomas.
    Spies SK; Snyman HW
    S Afr Med J; 1966 Dec; 40(44):1061-4. PubMed ID: 5334208
    [No Abstract]   [Full Text] [Related]  

  • 6. [A new methylhydrazine derivative (Ro 4-6467 or Natulan) in the treatment of Hodgkin's disease. Study of 10 cases].
    da Silva MP; Kerbauy J; de Guerra CC
    Rev Bras Med; 1966 Jul; 23(7):483-9. PubMed ID: 6014416
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experiences with the cytostatic drug natulan].
    Kohout J
    Med Klin; 1969 May; 64(19):898-901. PubMed ID: 5819002
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of some chronic hemoblastoses by a derivative of methylhydrazine (Natulan)].
    Quattrin N; Montuori R
    Acta Genet Med Gemellol (Roma); 1968 Jan; 17(1):178-9. PubMed ID: 4968995
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long term treatment of advanced vinblastine-resistant lymphogranulomatosis with ibenzmethyzin (Natulan)].
    Schulz E; Cissée H; Hausmann K
    Klin Wochenschr; 1970 Nov; 48(21):1291-9. PubMed ID: 4103872
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experiences with Natulan in the treatment of lymphogranulomatosis and reticulosarcomatosis].
    Wagner K; Haas H; Meyerhold A
    Wien Klin Wochenschr; 1965 Sep; 77(36):589-602. PubMed ID: 5323247
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chemotherapy of malignant systemic diseases with a methylhydrazine derivative, Natulan].
    Nissen I; Poulsen EH
    Ugeskr Laeger; 1967 Nov; 129(44):1472-6. PubMed ID: 4875225
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of Hodgkin's disease with Natulan].
    Anglesio E
    Minerva Med; 1965 Dec; 56(100):4402-6. PubMed ID: 5324896
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of treatment of lymphogranulomatosis with Natulan].
    Topolska P; Pawelski S
    Nowotwory; 1968; 18(3):251-5. PubMed ID: 4880772
    [No Abstract]   [Full Text] [Related]  

  • 14. [Long-term treatment of advanced lymphogranulomatosis using cytotoxic agents (Velbe, Natulan, Endoxan and Vincristine)].
    Schulz E; Hausmann K
    Verh Dtsch Ges Inn Med; 1968; 74():638-41. PubMed ID: 5714404
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical experience with procarbazine in Hodgkin's disease, reticulum cell sarcoma, and lymphosarcoma.
    Stolinsky DC; Solomon J; Pugh RP; Stevens AR; Jacobs EM; Irwin LE; Wood DA; Steinfeld JL; Bateman JR
    Cancer; 1970 Nov; 26(5):984-90. PubMed ID: 4920400
    [No Abstract]   [Full Text] [Related]  

  • 16. [Multiple drug therapy in Hodgkin's disease, lymphosarcoma and reticulosarcoma].
    Con I; Daiber A; Donoso A; Osorio G; Mora F
    Rev Med Chil; 1972 Apr; 100(4):408-13. PubMed ID: 4557485
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of systemic hemolymphopathies and of epithelial and connective-tissue neoplasms with a methylhydrazine derivative].
    Zarrilli D; Perrone V; Pergola M
    Clin Ter; 1966 Oct; 39(2):123-36. PubMed ID: 4871417
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study on antineoplastic chemotherapy of malignant lymphoma and the period of survival, with special reference to lymphatic reticulum cell sarcoma].
    Sakai Y
    Naika; 1968 Sep; 22(3):651-61. PubMed ID: 4884751
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the effect of a cytostatic of the methylhydrazine group on malignant hemoblastomas].
    Böhnel J; Stacher A
    Wien Med Wochenschr; 1966 May; 116(21):468-71. PubMed ID: 4863533
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of treatment of malignant granuloma with Natulan Roche].
    Lawkowicz W; Krzemińska-Lawkowiczowa ; Kolakowska-Polubiec K; Polubiec A
    Wiad Lek; 1968 Aug; 21(16):1417-9. PubMed ID: 5699696
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.